Acton Pharmaceuticals, Inc. Announces License Agreement with Sanofi U.S. for NASACORT HFA(TM) (triamcinolone acetonide) Nasal Aerosol
10/25/2011 6:57:41 AM
More...
|
Acton Pharmaceuticals, Inc. Announces Publication of AEROSPAN(R) (Flunisolide HFA) Pediatric Linear Growth Study in Annals of Allergy, Asthma & Immunology
10/11/2011 11:05:26 AM
More...
|
Acton Pharmaceuticals, Inc. Announces Additions to the Executive Management Team
5/5/2011 2:34:17 PM
More...
|
Acton Pharmaceuticals, Inc. Submits NDA Supplement to FDA for AEROSPAN(R) (flunisolide HFA, 80 mcg) Inhalation Aerosol
11/3/2010 10:16:12 AM
More...
|
Acton Pharmaceuticals, Inc. Forms Scientific Advisory Board
5/24/2010 9:58:55 AM
More...
|
Acton Pharmaceuticals, Inc. Announces Completion of $15 Million Series A Financing with Sequoia Capital
1/6/2010 7:09:22 AM
More...
|